FDA Investigator Gale E Ryan
Gale E Ryan has inspections in 8 countries as of 20 Nov 2023. Gale E Ryan has collaborated with a combined 2979 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
159
Last Inspection Date:
20 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Canada,
United Kingdom of Great Britain and Northern Ireland,
China,
Taiwan,
Switzerland,
Germany,
Italy
Co-Investigator(s):
Aaron L Morris,
Akbar J Zaidi,
Alberto A Viciedo,
Alice C Silva,
Alois P Provost,
Althea A Williams,
Alysia M Salonia,
Amanda T Zick,
Amy M Cramer,
Anabel Veiga,
Anne E Carpenter,
Anthony C Warchut,
Anthony N Onianwa,
Anthony W Thomas,
Arthur S Williams, Jr,
Ashar P Parikh,
Barbara J Rincon,
Barbara M Frazier,
Benjamin J Dastoli,
Bill Tacket, Jr,
Bradford L Swanson,
Brandon J Brookens,
Brenna L Macdowell,
Brian M Carril,
Bruce H Mccullough,
Carla A Norris,
Carol L Rehkopf,
Carr,
CDR Sean T Creighton,
Christopher J Cruciotti,
Christopher K Vantwuyver,
Christopher M Elliott,
Christopher T Smith,
Clara E Santiago,
Clausnitzer,
Clotia Cabbey Mensah,
Cullen T Wilson,
David P King,
David Perkins,
Dawn M Mccabe,
Diane C Thibodeau,
Dianiris C Ayala,
Diantha M Bleau,
Dominic R Frasca,
Donna Mwilliams Hill,
Douglas S Joslin,
Eduardo Carbonell,
Eduardo L Rodriguez,
Edward D Mcdonald,
Edward J Janik,
Edwards,
Edwin J Gorney,
Emily J Schramm,
Eric C Schmitt,
Eric R Holm,
Erin P Conlin,
Frank J Koch,
Gabriel E Muniz,
Gena M Mckahan,
Gerard D Difiore,
German Rivera,
Hunt,
Jacqueline S Warner,
James K Mcnally,
James To Neal,
James W Whitney,
Janete F Guardia,
Janis S Gallagher,
Jason A Rossi,
Jason D Tenney,
Jeffery A Hangartner,
Jeffrey J Thibodeau,
Jeffrey S Buckser,
Jennifer M Menendez,
Joan A Loreng,
Joel R Merriman,
John A Hollings,
John J Bernal,
John J Thibodeau,
John R Carlson,
Jonathan B Lewis,
Jose Alopez Rubet,
Joseph H Procopio,
Joshua J Silvestri,
Joyce A Kellett,
Juanita Banuelos,
Karen E D'orazio,
Karen M Rodriguez,
Katarzyna Plona,
Kellia N Hicks,
Kelly M Byers,
Kevin A Gonzales,
Kevin A Gonzalez,
Kimberly M White,
Kristen D Evans,
Lauren M Lawrance,
Lauren M Mclaughlin,
Laurie B Frazier,
Linda K Matheny,
Linda L Green,
Lirissia Mccoy,
Lisa M Lopez,
Lissette Paiz,
Liz M Otero,
Louis Christy,
LT Richard A Lyght,
Lyndsay M Perryman,
M Patriciaurphy Murphy,
Marc Balzarini,
Marcus F Yambot,
Mark R Mcclain,
Mary F Bodick,
Matthew B Casale,
Maxim,
Maya M Davis,
Meisha A Mandal,
Meyer J Slobotsky,
Michael C Lombardi,
Michael F Mccoy,
Michael G Mayfield,
Michael J Nerz,
Mikayla K Deardorff,
Mra Mcculloughj,
Niketa Patel,
Norman Wong,
Ormond,
Osama A Khatib,
Paige E Shelborne,
Paul M Kawamoto,
Pauline N Logan,
Rachel A Gomez,
Rebecca A Coleman,
Rebecca B Welch,
Rebecca C Maxim,
Reynolds,
Richard G Fochesato,
Richard H Penta,
Richard K Vogel,
Robert D Ogan,
Robert E Hatch,
Robert E Teel,
Robert G Antonsen, Jr,
Roger F Zabinski,
Rupa Pradhan,
Russell J Glapion,
Sally Gopaul,
Sarah Forney,
Sargum C Sood,
Shawn M Bogdan,
Simone E Pitts,
Simone Pins,
Souza,
Stacie A Woods,
Stanley B Eugene, BS, BME,
State Agency,
Stephen C Smith,
Stephen D Eich,
Stephen R Souza,
Steven B Hertz,
Stuart A Feldman,
Susan M Jackson,
Susant Hadman,
Suwaskie S Smith,
Teddy Tom,
Teresa I Navas,
Thomas Cote,
Thomas H Jenkins,
Thomas Siebertz,
Todd D Alspach,
Troy R Petrillo,
Victor Spanioli,
Wendy A Johnecheck,
William K Dagley,
Xiaojun Yan,
Yehualashet A Gessesse
Gale E Ryan's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2004 | FDA 483 | Sekisui Diagnostics, LLC - Form 483, 2004-08-10 |
April, 2008 | FDA 483 | Rossmax International Ltd. - Form 483, 2007-10-25 |
November, 2007 | FDA 483 | Rossmax (Shanghai) Inc., Ltd. - Form 483, 2007-11-01 |
March, 2008 | FDA 483 | Boston Scientific Corporation - Form 483, 2008-03-20 |
April, 2008 | EIR | Rossmax International Ltd. - EIR, 2007-10-25 |
August, 2001 | EIR | BlueTriton Brands, Inc. - EIR, 2001-08-16 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more